Posted by Michael Wonder on 08 Mar 2018
US cancer network recommending expensive drugs based on weak evidence, study finds
8 March 2018 - Study raises concerns about National Comprehensive Cancer Network, which publishes guidelines for American oncologists.
Guidelines for American oncologists often recommend expensive and harmful cancer drugs for patients based on “weak evidence”, according to a new study in the British Medical Journal.
he BMJ research looked at drugs recommended for conditions not approved by the US Food and Drug Administration, a practice called “off-label” prescribing.
